Description: HCi Viocare, formerly China Northern Medical Device, Inc., is a start-up enterprise. The Company is engaged in the research and development and marketing of medical technologies, and the operation of prosthetics and orthotics (P&O) and diabetic foot total rehabilitation clinics. It is also engaged in the technology development and licensing of bioengineering innovations for the health, sports and wellness sectors. It was formed to sell medical devices with an emphasis on portable medical devices designed for home treatments with the initial focus in the northern regions of China. It intends to seek strategic relationships with medical device manufacturers both in China and North America with the aim to be their sales and distribution agent in Northern China and to assist Chinese medical device manufacturers on the development of the North American market. Its subsidiaries include HCi Viocare Technologies Limited, HCi Viocare Clinics UK Limited and HCi Viocare Clinics (Hellas) S.A.
Home Page: rafina-innovations.com
Kintyre House
Glasgow,
G51 1HJ
United Kingdom
Phone:
44 1413 700 321
Officers
Name | Title |
---|---|
Mr. Constantinos Zertalis | Chairman, Pres & CEO |
Mr. Nikolaos Kardaras | Head of Legal Department |
Ms. Paraskevi Pilarinou | Financial Controller |
Ms. Paraskevi Pylarinou | CFO, Sec. & Director |
Dr. Hari Elangovan | Acting Chief Technology Officer |
Ms. Evaggelia Moschidou | Marketing Director |
Prof. Stephan Solomonidis | Head of Research |
Mr. Georgios Thrapsaniotis | Treasurer & Director |
Mr. Yiannis Levantis | Independent Technology Advisor & Director |
Exchange: PINK
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Providers & Services |
GIC Sub-Industry: | Health Care Facilities |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0 |
Price-to-Sales TTM: | 4.0454 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 4 |